Sionna Therapeutics, Inc.
NASDAQ:SIONBiotechnology
+$0.68 today
- Market cap
- $134.35M
- Beta
- 1.29
- P/E (TTM)
- -19.7
- EPS (TTM)
- -$1.90
Volume 0.52M
Average 0.39M
SION Other Non-current Liabilities
Long-term obligations not reported separately, such as lease or pension liabilities.
Sionna Therapeutics, Inc.NASDAQ: SION
Other Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other non-current liabilities remains negative
Q1 FY2026 other non-current liabilities was $0, compared with $0 a year earlier.
Context
- Other non-current liabilities amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Other non-current liabilities increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Other Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 330.37M | +121.7% |
| FY2023 | 2023-12-31 | 149.04M | +0.0% |
| FY2022 | 2022-12-31 | 149.04M | — |
Other Non-current Liabilities vs competitors
How SION compares with its peers on the latest reported figures
- SION's Mar 2026 other non-current liabilities of $0 is the 9th highest of the 11 companies compared; the peer median is $2.58M.
- Other non-current liabilities amounts to 0.0% of total assets for SION, versus a peer median of 0.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $229.35M | +4644.5% | +107.2% | 58.5% | |
| Sep 2026 | $190.71M | +13659.8% | -37.1% | 12.7% | |
| Sep 2026 | $92.09M | +33024.8% | -54.6% | 7.8% | |
| Mar 2026 | $25.86M | -2.5% | — | 5.1% | |
| Jun 2026 | $3.49M | -24.7% | +23.9% | 0.9% | |
| Jun 2026 | $1.68M | — | — | 0.3% | |
| Sep 2026 | $1.5M | -41.0% | -8.8% | 0.2% | |
| Mar 2026 | $388K | -61.4% | — | 0.1% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Sep 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding SION) | $2.58M | -2.5% | -8.8% | 0.6% | |
Competitors are the stored peer set for SION. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Sionna Therapeutics, Inc.
NASDAQ:SION
Intrinsic Alpha fair value
Locked
Current Price
$2.97
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.